Big Japanese price increase for NovoSeven
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has granted a rare reimbursement price increase for a prescription product, to Novo Nordisk's recombinant Factor VII product NovoSeven (eptacog alfa).